If you don’t have the funds to build a truly diverse portfolio, then exchange traded funds (ETFs) could be a quick fix. This is because ETFs allows you to invest in a large number of shares through just a single investment.

With that in mind, listed below are three ETFs that could be good options for investors. Here’s what you need to know about them:

BetaShares Asia Technology Tigers ETF (ASX: ASIA)

The BetaShares Asia Technology Tigers ETF could be a great option if you’re wanting to gain exposure to the growing Asian economy. That’s because this ETF gives investors access to a number of the best tech shares operating in the Asian market. By buying this ETF you’ll be owning a slice of well-known companies such as ecommerce giants Alibaba and JD.com, search engine company Baidu, and WeChat owner Tencent.

BetaShares Global Energy Companies ETF (ASX: FUEL)

Another ETF to look at is the BetaShares Global Energy Companies ETF. This ETF provides investors with a way to gain exposure to rising oil prices. This is by allowing investors to own a slice of some of the biggest energy companies in the world. BetaShares notes that these are larger, more geographically diversified, and more vertically integrated than Australian-listed energy companies. Among the fund’s holdings are the likes of BP, Chevron, ExxonMobil, and Royal Dutch Shell.

Vanguard MSCI Index International Shares ETF (ASX: VGS)

A final ETF for investors to look at is the Vanguard MSCI Index International Shares ETF. This ETF provides investors with exposure to a massive ~1,500 of the world’s largest listed companies, which could make it a good option for investors seeking to add some diversification to a portfolio. Among the companies you’ll be investing in are giants such as Amazon, Apple, Johnson & Johnson, JP Morgan, Nestle, Procter & Gamble, and Visa.

The post 3 high quality ETFs for ASX investors to buy today appeared first on The Motley Fool Australia.

More reading

• Is the Vanguard International Shares ETF just a big bet on the FANG stocks?
• 3 exciting ETFs for ASX investors to buy today
• 2 popular ETFs for investors to buy in April
• How did the Vanguard MSCI Index International Shares ETF fare in March?
• Here are the 5 best-performing ASX exchange-traded funds over the March quarter

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended BetaShares Global Energy Companies ETF – Currency Hedged and Vanguard MSCI Index International Shares ETF. The Motley Fool Australia has recommended BetaShares Asia Technology Tigers ETF and Vanguard MSCI Index International Shares ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/sLED8Bn

Today, the S&P/ASX 200 Index (ASX: XJO) barely snuck through with a positive finish after losing steam throughout the day. At the end of the session, the benchmark index finished 0.05% higher at 7,569.2 points.

It was a booming day for the healthcare sector as it returned 2.6% for the day — making it the best performing area of the market. The superior performance was largely thanks to a $20 billion takeover bid for Ramsay Health Care Ltd (ASX: RHC) (more on that later).

Whereas, materials were the most red of all sectors on Wednesday. Investors decided to take some profits from the high-flying lithium sector as prices for the battery commodity cool off, according to Benchmark Minerals Intelligence.

However, the question is: which shares delivered the biggest returns to investors on the ASX today? Here are the top ten stocks that came through for investors:

Top 10 ASX shares countdown today

Looking at the top 200 listed companies, Ramsay Health Care was the biggest gainer today. Shares in the private hospital operator took flight following a confirmed takeover bid at $88 per share from a consortium led by KKR. At the end of the day, shares in the company finished 24.24% higher. Find out more about Ramsay Health Care here.

Following from afar as the second-best performing ASX share of the day was medical imaging company, Pro Medicus Ltd (ASX: PME). Despite a lack of announcements, shares in the company rallied 5.20% to $51.61. Uncover the latest Pro Medicus details here.

Today’s top 10 biggest gains were made in these ASX shares:

ASX-listed company	Share price	Price change
Ramsay Health Care Ltd (ASX: RHC)	$80.00	24.24%
Pro Medicus Ltd (ASX: PME)	$51.61	5.20%
Healius Ltd (ASX: HLS)	$4.56	3.64%
Corporate Travel Management Ltd (ASX: CTD)	$25.35	3.60%
Ansell Ltd (ASX: ANN)	$26.14	3.44%
Whitehaven Coal Ltd (ASX: WHC)	$4.80	3.00%
Bapcor Ltd (ASX: BAP)	$6.78	2.73%
The A2 Milk Company Ltd (ASX: A2M)	$4.72	2.61%
Webjet Ltd (ASX: WEB)	$5.96	2.58%
Block Inc (ASX: SQ2)	$167.75	2.53%

Our top 10 ASX shares today countdown is a recurring end-of-day summary to ensure you know which companies were making big moves on the day. Check-in at Fool.com.au after the market has closed during weekdays to see which stocks make the countdown.

The post Here are the top 10 ASX shares today appeared first on The Motley Fool Australia.

More reading

• This struggling ASX BNPL share is delisting. What does this mean?
• Why Alliance Aviation, Life360, Ramsay Health Care, and Whitehaven Coal are racing higher
• Here are the 3 most heavily traded ASX 200 shares on Wednesday
• ASX 200 midday update: Ramsay rockets and Rio Tinto disappoints
• Ramsay Health Care share price rockets 28% higher on takeover bid

Motley Fool contributor Mitchell Lawler owns Block, Inc. and Pro Medicus Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Block, Inc. and Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Block, Inc. and Pro Medicus Ltd. The Motley Fool Australia has recommended A2 Milk, Ansell Ltd., Bapcor, Corporate Travel Management Limited, Ramsay Health Care Limited, and Webjet Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/h5C7GoM

The CSL Limited (ASX: CSL) share price has edged lower since this time last month, down 2.38%.

While the global biotech didn’t release any market-sensitive news, investors appeared to be mixed about the company’s shares.

At market close on Wednesday, CSL shares finished trading at $264.50, up 0.82%.

What’s weighing down CSL shares?

A number of factors are playing against CSL shares for the moment as the COVID-19 pandemic begins to subside.

First and foremost, the S&P/ASX 200 Health Care Index (ASX: XHJ) has moved sideways since the start of 2022.

Investors appear to have focused their efforts on other performing sectors on the ASX such as the S&P/ASX 300 Metals & Mining Index (ASX: XMM). This consists of the top 300 ASX companies that are involved with gold, steel and precious metals.

And it is no surprise given the war in Ukraine, and inflationary movements that commodity prices have skyrocketed.

Market psychology can be a powerful force when crowd behaviour chases market rallies or sell-offs during downturns.

In addition, the company’s first half results provided an update on its plasma collection issues. It noted that plasma numbers were 18% higher than H1 FY21, but still slightly down on 2019 levels.

CSL opened 18 new facilities in the first half of FY22 to attract lapsed and new donors through its doors. For the remainder of the financial year, the company plans to open another 35 centres, expanding its presence, mostly across the United States.

Nonetheless, a number of brokers rated the company’s shares to pick up over the course of the year.

Morgan Stanley raised its outlook to “overweight” from “equal weight”, adding 7.9% to a 12-month price target of $302.

Based on the current CSL share price, this implies a potential upside of 14.2%.

Meanwhile, Citi cut its rating on CSL shares by 1.5% to $335. Based on Citi’s assessment, this implies an upside of almost 27% from where it trades today.

CSL share price summary

When looking from this time last year, the CSL share price has moved in circles registering a less than 15 gain.

Year to date has not fared well, losing 9% in value across the 4-month period. 

CSL commands a market capitalisation of roughly $127.41 billion, making it the third largest company on the ASX.

The post Why has the CSL share price struggled in the past month? appeared first on The Motley Fool Australia.

More reading

• Should ASX investors buy the dip in the CSL share price?
• 2 blue chip ASX 200 shares analysts rate as buys this month
• Top brokers name 3 ASX shares to buy today
• ASX 200 healthcare shares were chronically ill last quarter. Take a look
• How is the CSL share price performing against its sector in 2022?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/nO4t5PB

Of all the US shares that have captured the minds of Aussie investors in recent years, electric vehicle and battery manufacturer Tesla Inc (NASDAQ: TSLA) surely comes close to topping the list.

For one, Tesla’s meteoric rise from US$38 a share back in May 2019 to the all-time high of US$1,243.49 that we saw in November last year was enough to turn some heads. And there are also the meme-friendly antics of eccentric Tesla CEO Elon Musk over the years to consider as well. Throw in the rabid interest that investors have developed for ‘clean and green’ companies, and we can begin to understand the fascination over Tesla that many investors have developed.

But with such a steep share price rise over the past few years, many investors might be wondering where this now-US$1.06 trillion company is headed next. What could possibly follow a three-year return of close to 1,800%?

Well, according to Cathie Wood, another quadrupling. Wood is a US-based investor and fund manager well-known for her bullish outlook on tech shares in particular. She runs ARK Invest, which is a firm that specialises in creating US tech-based ETFs such as the flagship ARK Innovation ETF (NYSE: ARKK). Wood has never been shy to spruik Tesla before. Her fund was an early investor in the company and has likely already made windfalls on investing in Tesla.

Cathie Wood: Tesla stock price to hit US$4,600, possibly US$5,800

But according to a report in the Australian Financial Review (AFR) this week, Wood is doubling down on Tesla. She is calling a US$4,600 Tesla stock price by 2026, which would be more than a four-fold increase on where the shares sit today. That’s up from ARK’s previous prediction of a US$3,000 Tesla stock price by 2025. ARK reportedly also has a ‘bull‘ and ‘bear‘ case for Tesla too. Its bear case still has the company at US$2,900 by 2026, but its bull case scenario is a whopping valuation of US$5,800 by the same year.

These revised valuation models reportedly factor in Tesla’s prospective ‘robotaxi’ business, as well as its “capital efficiencies”.

So could the company really reach those heights? Well, we can’t know for sure today. But Wood was one of the few voices arguing Tesla would be a multi-bagger in 2019 when few others were.

However, the AFR report also cites a more pessimistic analyst in David Trainer, CEO of investment researcher New Constructs. Trainer sees Tesla shares at just US$150-$200 in the future, citing Tesla’s loss of its first-mover advantage in the electric vehicle space, and intensifying competition. 

Time will only tell who proves to be right on Tesla’s stock price. But no doubt it will still have investors’ attention, whichever way it goes. 

The post Can the Tesla share price really quadruple from here? appeared first on The Motley Fool Australia.

More reading

• Why Tesla stock popped before earnings
• Why Tesla stock popped on Monday
• Better stock-split buy: Tesla vs. GameStop
• Shopify, Alphabet, Amazon, and Tesla stocks are splitting — which ones are the best buys?
• Why Ethereum and Dogecoin are down today

Motley Fool contributor Sebastian Bowen owns Tesla. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Tesla. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/VmjbRXf